BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23425616)

  • 1. [Editorial: Hebebrand, J., Blanz, B., Herpertz-Dahlmann, B. & Lehmkuhl, G. 2012. Increase in the abundance of medical treatments, ethical principles and conflicts of interest in cooperation with the pharmaceutical industry].
    Frank R
    Z Kinder Jugendpsychiatr Psychother; 2013 Mar; 41(2):145-9. PubMed ID: 23425616
    [No Abstract]   [Full Text] [Related]  

  • 2. [Increase in incidence of drug treatments, ethical principles and conflict of interest in cooperation with the pharmaceutical industry].
    Hebebrand J; Blanz B; Herpertz-Dahlmann B; Lehmkuhl G
    Z Kinder Jugendpsychiatr Psychother; 2012 May; 40(3):133-8. PubMed ID: 22774235
    [No Abstract]   [Full Text] [Related]  

  • 3. Financial incentives and the prescription of newer vaccines by doctors in India.
    Lodha R; Bhargava A
    Indian J Med Ethics; 2010; 7(1):28-30. PubMed ID: 20166294
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.
    Steinman MA; Schillinger D
    Am J Bioeth; 2010 Jan; 10(1):21-3. PubMed ID: 20077331
    [No Abstract]   [Full Text] [Related]  

  • 5. Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan.
    Saito H; Tani Y; Ozaki A; Sawano T; Shimada Y; Yamamoto K; Tanimoto T
    Clin Microbiol Infect; 2019 Nov; 25(11):1304-1306. PubMed ID: 31401175
    [No Abstract]   [Full Text] [Related]  

  • 6. The medical trade.
    Bawaskar HS
    Indian J Med Ethics; 2013; 10(4):278. PubMed ID: 24152357
    [No Abstract]   [Full Text] [Related]  

  • 7. Mixing Dinner and Drugs-Is It Ethically Contraindicated?
    Essi DF
    AMA J Ethics; 2015 Aug; 17(8):787-95. PubMed ID: 26270881
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing.
    Hadland SE; Cerdá M; Li Y; Krieger MS; Marshall BDL
    JAMA Intern Med; 2018 Jun; 178(6):861-863. PubMed ID: 29799955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Note from the editor.
    Freedman R
    Am J Psychiatry; 2010 Nov; 167(11):1407. PubMed ID: 21041255
    [No Abstract]   [Full Text] [Related]  

  • 10. [Conflicts of interest in clinical practice. Ethical analysis of some relationships with the pharmaceutical industry].
    Salas SP; Osorio F M; Vial C P; Rehbein V AM; Salas A C; Beca I JP
    Rev Med Chil; 2006 Dec; 134(12):1576-82. PubMed ID: 17277877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should physicians rely on pharmaceutical detailing for their education?
    van Schalkwyk JM; Turner MJ
    J Clin Hypertens (Greenwich); 2013 Mar; 15(3):218. PubMed ID: 23458597
    [No Abstract]   [Full Text] [Related]  

  • 12. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
    De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G
    PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doctors behaving badly?
    Tattersall MH; Kerridge IH
    Med J Aust; 2006 Sep; 185(6):299-300. PubMed ID: 16999666
    [No Abstract]   [Full Text] [Related]  

  • 14. [Conflicts of interest: an academic proposal].
    Lama A
    Rev Med Chil; 2006 Jun; 134(6):800. PubMed ID: 17130959
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of financial relationships on the behaviors of health care professionals: a review of the evidence.
    Robertson C; Rose S; Kesselheim AS
    J Law Med Ethics; 2012; 40(3):452-66. PubMed ID: 23061573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No more free drug samples?
    Chimonas S; Kassirer JP
    PLoS Med; 2009 May; 6(5):e1000074. PubMed ID: 19434227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical commerce, physician entrepreneurialism, and conflicts of interest.
    Rodwin MA
    Camb Q Healthc Ethics; 2007; 16(4):387-97; discussion 439-42. PubMed ID: 18018918
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries.
    Mitchell AP; Winn AN; Dusetzina SB
    JAMA Intern Med; 2018 Jun; 178(6):854-856. PubMed ID: 29630687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Take this medicine: the legality of prescription incentive schemes.
    Fanning J; Glover-Thomas N
    Med Law Rev; 2010; 18(3):417-26. PubMed ID: 20739438
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical registries: Should physicians accept payments for enrolling patients?
    Jariwala N; Lipoff JB
    J Am Acad Dermatol; 2017 Jul; 77(1):183-185. PubMed ID: 28619564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.